Otitis Externa

Overview

Otitis externa is an acute or chronic inflammation of the external auditory canal, which extends from the tympanic membrane to the pinna. It is predominantly a localized bacterial infection caused by a breakdown in the natural protective barriers of the ear canal—namely cerumen, an acidic pH, and an intact epithelial lining. Frequently referred to as “swimmer’s ear,” the condition manifests clinically as intense otalgia, otorrhea, and canal erythema and edema.

Epidemiologically, otitis externa is a widespread condition affecting approximately 1 in 10 individuals at least once in their lifetime, with an estimated annual incidence of 1% in the general population. It affects all age groups but shows a strong peak incidence in children aged 7 to 12 years. The condition exhibits pronounced seasonal variation, with a four-fold increase in incidence during summer months, directly correlated with higher ambient humidity, warmer temperatures, and increased participation in aquatic activities.

Anatomy

Nerve	Supply
Great auricular (C2, C3)	Cranial surface of auricle and the lower part of the lateral surface of auricle
Auriculotemporal branch of the trigeminal nerve	Upper part of the lateral surface and most of the meatal skin
Facial nerve	Posterior–inferior portion of the external ear canal and adjacent tympanic membrane
Glossopharyngeal nerve tympanic branch	Mucosal surface of tympanic membrane
Vagus – auricular branch ‘Arnold’s nerve’	Supplies small areas of skin on the cranial auricular surface, posterior wall and floor of the meatus and adjoining part of the tympanic membrane

Classification

By Duration

• Acute Otitis Externa: Sudden onset lasting less than 6 weeks, characterized by rapid development of canal inflammation and severe otalgia.
• Chronic Otitis Externa: Persistent inflammation of the external auditory canal lasting longer than 3 months, often secondary to dermatological conditions, inadequate initial treatment, or persistent moisture.

By Clinical Pattern

• Acute Diffuse Otitis Externa (Classic Swimmer’s Ear): Widespread bacterial inflammation of the entire canal skin; accounts for over 90% of acute presentations.
• Acute Localized Otitis Externa (Furunculosis): Infection of a single hair follicle in the outer cartilaginous portion of the canal, typically caused by Staphylococcus aureus.
• Otomycosis: Primary or secondary fungal infection of the canal space.
• Malignant / Necrotizing Otitis Externa: Invasive osteomyelitis of the temporal bone and skull base.

Aetiology & Risk Factors

Aeriology

• Bacterial Pathogens (Most Common)
  • Pseudomonas aeruginosa: The predominant bacterial pathogen (~38–50% of cases).
  • Staphylococcus aureus: Second most common bacterial cause (~9–27% of cases).
  • Polymicrobial / Other Aerobes: Proteus mirabilis, Klebsiella pneumoniae, and Escherichia coli.
• Fungal Pathogens (Otomycosis)
  • Aspergillus species: Aspergillus niger (classic black dots/spores) and Aspergillus fumigatus; accounts for 80–90% of fungal cases.
  • Candida species: Candida albicans (thick white “curd-like” exudate).

Risk Factors

• Moisture & Maceration: Frequent swimming, aquatic sports, humid climates, or excessive perspiration (disrupts cerumen barrier and raises canal pH).
• Mechanical Micro-Trauma: Cotton buds (Q-tips), fingernails, earplugs, hearing aids, or aggressive ear irrigation.
• Dermatological Conditions: Eczema, psoriasis, seborrheic dermatitis, or contact dermatitis from topical ear drop preservatives.
• Systemic Risk Factors: Diabetes mellitus, advanced age, chemotherapy, HIV/AIDS, or other immunosuppressive states.

Pathophysiology

• Loss of Protective Barrier: Healthy cerumen provides an acidic hydrophobic coating (pH 4.0–5.0) that inhibits bacterial growth. Water exposure or trauma removes cerumen and creates an alkaline, moist environment.
• Bacterial Invasion: Opportunistic bacteria (P. aeruginosa) invade macerated epithelial layers and multiply in the warm, dark environment.
• Severe Pain Mechanism: Skin of the external canal is extremely thin and tightly adherent to the underlying periosteum and perichondrium. Inflammatory edema within this unyielding space causes high tissue pressure, producing severe pain out of proportion to physical findings.

Clinical Manifestations

Symptoms

• Severe Otalgia
• Pruritus
• Otorrhea: Clear, purulent, or foul-smelling ear discharge (greenish in Pseudomonas, black/white in fungal otomycosis).
• Conductive Hearing Loss & Fullness

Clinical examination

• Tragal & Pinna Tenderness (pathognomonic sign).
• Canal Edema & Erythema: Diffuse narrowing of the external auditory canal, ranging from mild redness to complete luminal obliteration.
• Debris & Exudate
• Tympanic Membrane Appearance: Intact and mobile (if visible), though often obscured by canal edema.

High-Risk / Malignant Features

• Granulation Tissue: Red granulation tissue on the floor of the external auditory canal at the cartilaginous-bony junction (hallmark of Necrotizing Otitis Externa).
• Cranial Nerve Palsies: Facial nerve (CN VII) weakness (most common), followed by glossopharyngeal (CN IX), vagus (CN X), and accessory (CN XI) nerve deficits due to skull base extension.

---

Diagnosis

• Clinical Diagnosis: based on history and otoscopic examination.
• Ear Canal Swab & Culture: Indicated in treatment failure, recurrent infection, otomycosis suspicion, or immunocompromised patients.
• Blood Tests (for Suspected Malignant OE)
• Diagnostic Imaging (for Suspected Malignant OE):
  • CT Scan of Temporal Bone: Demonstrates bony erosion and soft tissue extension at the skull base.
  • Technetium-99m / Gallium-67 Scans: Highly sensitive bone scans used to confirm osteomyelitis and monitor response to prolonged IV antimicrobial therapy.

Treatment

Principles of Management

• Aural Toilet: Gentle removal of debris, cerumen, and purulent exudate using micro-suction or dry cotton wipes under direct visualization to allow topical drops to contact canal skin.
• Topical Antimicrobial & Corticosteroid Drops (First-Line):
  • Ciprofloxacin + Dexamethasone or Ofloxacin: Non-ototoxic combination drops; safe even if tympanic membrane perforation cannot be ruled out.
  • Acetic Acid 2% Drops: Restores normal acidic canal pH; effective for mild early cases.
  • Neomycin / Polymyxin B / Hydrocortisone: Effective option, but contraindicated if the tympanic membrane is perforated due to aminoglycoside ototoxicity.
• Ear Wick Placement: Indicated when canal edema is so severe that drops cannot penetrate. An expandable wick is inserted, saturated with topical drops, and changed every 24–48 hours until edema subsides.
• Analgesia: Regular oral NSAIDs (Ibuprofen) or Paracetamol for severe inflammatory pain; short-course oral opioids may be required initially.
• Systemic Antibiotics: NOT indicated for uncomplicated acute diffuse otitis externa.
  • Indicated ONLY if:
    • Infection spreads beyond the ear canal (cellulitis of pinna or face).
    • Concurrent diabetes mellitus, severe immunocompromise, or high risk of malignant OE.
    • Malignant Otitis Externa (requires prolonged high-dose IV Ciprofloxacin or Ceftazidime).
• Water Precautions: Strict dry ear precautions (keep ear dry during bathing using cotton balls coated in petroleum jelly; no swimming for at least 7–10 days).

Complications & Prognosis

Complications

• Malignant (Necrotizing) Otitis Externa
• Auricular Cellulitis
• Canal Stenosis & Medial Fibrosis
• Tympanic Membrane Perforation

Prognosis

• Uncomplicated Acute OE: Excellent; symptoms typically improve within 48–72 hours of starting appropriate topical drops and resolve completely within 7–10 days.
• Malignant OE: High morbidity and potential mortality requiring 6–12 weeks of targeted parenteral antibiotic therapy.

References

1. Rosenfeld RM, Schwartz SR, Cannon CR, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014;150(2 Suppl):S1-S24. doi:10.1177/0194599813517083
2. Schaefer P, Baugh RF. Acute otitis externa: an update. Am Fam Physician. 2012;86(11):1055-1061.
3. Wiegand S, Berner R, Dietz A, Wittekindt C, Hüttenbrink KB. Otitis Externa. Dtsch Arztebl Int. 2019;116(13):224-234. doi:10.3238/arztebl.2019.0224